Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03674229 · ClinicalTrials.gov registry record · NA

Patients Navigators in Facilitating Weight Management in Obese Participants

A NA study of Obesity and Health Status Unknown, sponsored by M.D. Anderson Cancer Center.

Active
Registry status
NA
Development phase
171
Enrollment target
1
Study location

NCT03674229 is a NA study of Obesity and Health Status Unknown that is active but no longer recruiting, run by M.D. Anderson Cancer Center. The registered enrollment target is 171 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (79% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03674229, a NA study of Obesity and Health Status Unknown, is active but no longer recruiting, sponsored by M.D. Anderson Cancer Center.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
171 participants
Enrollment target
1
Study location

Study Summary

This trial studies the effectiveness of patient navigators in facilitating weight management in obese participants. Health coaches or patient navigators may help more participants take part in weight management programs.

Interventions

  • OTHER Questionnaire Administration
  • OTHER Informational Intervention
  • BEHAVIORAL Telephone-Based Intervention

Study Locations (1)

Texas

  • M D Anderson Cancer Center - Houston

Trial Details

FieldValue
Enrollment Target 171 participants
Start Date 2015-07-02
Est. Completion 2030-10-01
Phase NA

Sponsor

M.D. Anderson Cancer Center

2,692 total trials

What the Registry Record Tells You About NCT03674229

The ClinicalTrials.gov registry entry for NCT03674229 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 171 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (79% lower). The listed sponsor is M.D. Anderson Cancer Center, which has 2,692 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Obesity appearing as the primary indexed condition, and to 3 interventions - of which Questionnaire Administration is the first listed.

NCT03674229 reports 1 study location spanning 1 distinct geographic area - top geographies include Texas.

Frequently Asked Questions

What is clinical trial NCT03674229 about?

NCT03674229 is a clinical study titled "Patients Navigators in Facilitating Weight Management in Obese Participants". This trial studies the effectiveness of patient navigators in facilitating weight management in obese participants. Health coaches or patient navigators may help more participants take part in weight management programs.

What is the current status of trial NCT03674229?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 171 participants. The study started on 2015-07-02. Estimated completion is 2030-10-01.

What conditions does trial NCT03674229 study?

This clinical trial studies the following conditions: Obesity, Health Status Unknown.

What interventions are being tested in trial NCT03674229?

The interventions under investigation include: Questionnaire Administration (OTHER), Informational Intervention (OTHER), Telephone-Based Intervention (BEHAVIORAL).

Who is sponsoring clinical trial NCT03674229?

This trial is sponsored by M.D. Anderson Cancer Center, which has 2,692 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03674229 being conducted?

This trial has 1 study location across Texas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.